Investor News
| May 14, 2020 |
Clariant confirms extraordinary distribution but proposes to withhold regular dividend
Due to the uncertain economic environment in light of the COVID-19 pandemic, Clariant's Board of Directors has confirmed the extraordinary distribution while proposing to withhold the distribution of the regular dividend. more |
|---|---|
| April 30, 2020 |
Clariant profitability remains resilient despite difficult economic environment
Clariant today announces first quarter 2020 continuing operations sales of CHF 1.019 billion compared to CHF 1.164 billion in the first quarter of 2019. more |
| April 29, 2020 |
Clariant to hold Annual General Meeting on 29 June 2020
The 25th Annual General Meeting (AGM) will take place on 29 June 2020, at 10:30 a.m. at the Congress Center Basel, Messeplatz 21, 4058 Basel, Switzerland. more |
| March 18, 2020 |
Clariant to postpone Annual General Meeting planned for March 30, 2020
Against the background of the worldwide spread of the coronavirus (SARS-CoV-2), the Swiss Federal Council implemented the COVID-19 Ordinance 2 which sets new rules for Annual General Meetings, effective March 16, at midnight. As a consequence of this declaration by the Swiss Federal Council, no shareholders are admitted to attend the General Meeting in person. However, the company may order that participants may exercise their rights exclusively in writing or in electronic form or through an independent proxy appointed by the company. more |
| March 09, 2020 |
Clariant presents its Integrated Report 2019
Clariant, a focused and innovative specialty chemical company, today published its Integrated Report 2019. It gives a detailed overview of the company’s multidimensional approach to value creation, covering both tangible and intangible, and financial and nonfinancial aspects of its business. more |
| February 20, 2020 |
Clariant proposes two new candidates for the Board of Directors
The Board of Directors decided to propose Mr. Nader Ibrahim Alwehibi and Mr. Thilo Mannhardt for election to the Board of Directors at its Annual General Meeting. The nominees will replace the current Board members Mr. Khaled Homza A. Nahas and Mr. Carlo G. Soave. more |
| February 13, 2020 |
Clariant grows sales and improves underlying profitability in 2019
Clariant, a focused and innovative specialty chemical company, today announced full year 2019 continuing operations sales of CHF 4.399 billion, compared to CHF 4.404 billion in 2018. This corresponds to organic growth of 3 % in local currency and is a stable development in Swiss francs due to unfavorable currency fluctuations. The sales increase in local currency was driven by the Business Areas Catalysis and Natural Resources and was supported by both higher volumes and pricing. |
| February 12, 2020 |
Stephan Lynen to become new CFO of Clariant
Clariant, a focused and innovative specialty chemical company, today announced that Stephan Lynen will be appointed CFO as of April 1, 2020. The proven financial expert, currently Head of the Business Unit Additives, has been with the company for more than 20 years in various international general management and business roles. He will succeed Patrick Jany who decided to pursue a career opportunity outside of Clariant. more |
| December 19, 2019 |
Clariant has agreed to sell its Masterbatches business for approx. USD 1.6 billionClariant, a focused and innovative specialty chemical company, has agreed to sell its entire Masterbatches business to PolyOne. The transaction values the Masterbatches business at USD 1,560 million, representing c. 12.2 times the last twelve months reported EBITDA (ending September 2019) on a cash and debt free basis. This amount is payable at closing, which is expected by Q3 2020. more |
| November 29, 2019 |
Clariant and Plant Advanced Technologies (PAT) sign a strategic partnership to revolutionize the cosmetics industryClariant and Plant Advanced Technologies (PAT) announce the establishment of a strategic partnership. It includes the subscription of approx. 10% equity shares of PAT by Clariant, joint development agreement and exclusive distributionship. Renowned for its highly sustainable and cutting edge technologies, PAT develops unique and powerful plant-based active ingredients for cosmetics. more |
| October 31, 2019 |
Clariant completes the sale of its Healthcare Packaging businessClariant, a focused and innovative specialty chemical company, today announced the completion of the sale of its Healthcare Packaging business to a newly-formed investment of Arsenal Capital Partners, the signing of which was announced on July 22, 2019. The sale was closed on October 31, 2019. more |
| October 30, 2019 |
Clariant welcomes Bernd Hoegemann as new member of the Executive CommitteeClariant, a focused and innovative specialty chemical company, today announced that its Board of Directors has decided to appoint Bernd Hoegemann as the newest member of the company’s Executive Committee. Bernd Hoegemann has been with the company for over 10 years and is currently Clariant’s Head of Business Unit Masterbatches. more |
| October 30, 2019 |
Clariant grows sales and improves underlying profitability in the first nine months of 2019“Our nine months results reflect the resilience and quality of our continuing businesses, in particular in light of the worsening economic environment in the third quarter,” said Hariolf Kottmann, Executive Chairman of Clariant. “Looking forward, we will continually improve our performance through further operational improvement initiatives and the systematic implementation of our portfolio strategy to focus on higher value specialty businesses.” more |
| October 01, 2019 |
Restated 2018 figures and additional 2019 financials availableClariant, a focused and innovative specialty chemical company, today published restated 2018 results and additional 2019 financials on the Investor Relations website. more |
| September 20, 2019 |
Clariant and ORLEN Południe announce license agreement on sunliquid® cellulosic ethanol technologyClariant, a focused and innovative specialty chemical company, and ORLEN Południe, a member of ORLEN Group, which is a leader in the fuels and energy markets and the largest player in Central and Eastern Europe, today signed a license agreement on sunliquid cellulosic ethanol technology. more |
| July 25, 2019 |
Clariant to focus on its core high value specialty businessesClariant and SABIC have agreed to temporarily suspend the discussions on the intended business combination High Performance Materials (HPM), consisting of Clariant’s Additives and high value Masterbatches and parts of SABIC’s Specialties business. more |
| July 25, 2019 |
Clariant grows sales and operating cash flow in the first half year 2019“The first half year 2019 was admittedly challenging - particularly the second quarter, which was additionally impacted by temporary negative influences and one-off occurrences. Our continuing businesses showed resilience in this difficult environment, which comforts us in our strategic decision to divest Masterbatches and Pigments,” said Hariolf Kottmann, Executive Chairman of Clariant. “Despite the uncertainties of the current economic environment, the growth profile of our continuing portfolio remains unchanged. We will continue to intensify our focus on customer experience and fast reliable customer fulfillment, enabling Clariant to realize above-market growth, higher profitability and stronger cash generation.” more |
| July 24, 2019 |
Clariant’s Board of Directors accepted resignation of CEO Ernesto OcchielloClariant, a focused and innovative specialty chemical company, today announced that Ernesto Occhiello, Chief Executive Officer and Member of the Executive Committee, has decided to leave the company for personal reasons with immediate effect. The Board of Directors accepted his resignation yesterday. The Board of Directors asked Hariolf Kottmann, Chairman of the Board of Directors of Clariant, to assume his responsibilities in the interim as Executive Chairman until a successor is found. more |
| July 22, 2019 |
Clariant signs an agreement regarding the sale of its Healthcare Packaging BusinessClariant, a focused and innovative specialty chemical company, has signed an agreement with respect to the sale of its Healthcare Packaging business to a newly-formed affiliate of Arsenal Capital Partners. The total consideration of the sale amounts to approximately CHF 308 million payable at closing, which is expected in Q4 2019. The total consideration is equivalent to 13.2 times adjusted FY2018 EBITDA. The closing of the transaction is subject to customary conditions and approvals. more |
| June 18, 2019 |
Christian Kohlpaintner leaves Clariant after 10 successful yearsClariant, a focused and innovative specialty chemical company, today announced that Christian Kohlpaintner, Member of the Executive Committee, decided to resign from his position effective June 30, 2019, to take on new challenges outside the company. more |
